The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
Open accessAbstract
The identification of the neutralization domains of hepatitis C virus (HCV) is essential for the development of an effective vaccine. Here, we show that the hypervariable region 1 (HVR1) of the envelope 2 (E2) protein is a critical neutralization domain of HCV. Neutralization of HCV in vitro was attempted with a rabbit hyperimmune serum raised against a homologous synthetic peptide derived from the HVR1 of the E2 protein, and the residual infectivity was evaluated by inoculation of HCV-seronegative chimpanzees. The source of HCV was plasma obtained from a patient (H) during the acute phase of posttransfusion non-A, non-B hepatitis, which had been titered for infectivity in chimpanzees. The anti-HVR1 antiserum induced protection against homologous HCV infection in chimpanzees, but not against the emergence of neutralization escape mutants that were found to be already present in the complex viral quasispecies of the inoculum. The finding that HVR1 can elicit protective immunity opens new perspectives for the development of effective preventive strategies. However, the identification of the most variable region of HCV as a critical neutralization domain poses a major challenge for the development of a broadly reactive vaccine against HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic organization and diversity of the hepatitis C virus.
Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., & Barr, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2451 · Cited by 1,716
Martell, M., Esteban, J. I., Quer, J., Genescà, J., Weiner, A., Esteban, R., Guardia, J., & Gómez, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3225-3229.1992 · Cited by 930
Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes
Bukh, J., Miller, R., & Purcell, R. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007262 · Cited by 833
Self-citationLack of Protective Immunity Against Reinfection with Hepatitis C Virus
Farci, P., Alter, H. J., Govindarajan, S., Wong, D. C., Engle, R., Lesniewski, R. R., Mushahwar, I. K., Desai, S. M., Miller, R. H., Ogata, N., et al. (1992) · Science · doi:10.1126/science.1279801 · Cited by 752
Self-citationWeiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 704
Weiner, A. J., Brauer, M. J., Rosenblatt, J., Richman, K. H., Tung, J., Crawford, K., Bonino, F., Saracco, G., Choo, Q.-L., Houghton, M., et al. (1991) · Virology · doi:10.1016/0042-6822(91)90104-j · Cited by 609
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.
Ogata, N., Alter, H. J., Miller, R. H., & Purcell, R. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3392 · Cited by 606
Self-citationVaccination of chimpanzees against infection by thehepatitis C virus.
Choo, Q. L., Kuo, G., Ralston, R., Weiner, A., Chien, D., Van Nest, G., Han, J., Berger, K., Thudium, K., & Kuo, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1294 · Cited by 575
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
Farci, P., Alter, H. J., Wong, D., Miller, R. H., Shih, J. W., Jett, B., & Purcell, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250205 · Cited by 571
Self-citationPrevalence of chronic liver disease in the general population of northern Italy: The dionysos study
Bellentani, S., Tiribelli, C., Saccoccio, G., Sodde, M., Fratti, N., De Martin, C., & Christianini, G. (1994) · Hepatology · doi:10.1002/hep.1840200611 · Cited by 517
Farci, P., Alter, H. J., Wong, D. C., Miller, R. H., Govindarajan, S., Engle, R., Shapiro, M., & Purcell, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7792 · Cited by 486
Self-citationShimizu, Y. K., Hijikata, M., Iwamoto, A., Alter, H. J., Purcell, R. H., & Yoshikura, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1494-1500.1994 · Cited by 405
Self-citationKato, N., Sekiya, H., Ootsuyama, Y., Nakazawa, T., Hijikata, M., Ohkoshi, S., & Shimotohno, K. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3923-3930.1993 · Cited by 374
Hypervariable regions in the putative glycoprotein of hepatitis C virus
Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., & Shimotohno, K. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81223-9 · Cited by 348
Rosa, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dong, C., Weiner, A. J., Lau, J. Y., Choo, Q. L., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1759 · Cited by 344
KOZIOL, D. E., HOLLAND, P. V., ALLING, D. W., MELPOLDER, J. C., SOLOMON, R. E., PURCELL, R. H., HUDSON, L. M., SHOUP, F. J., KRAKAUER, H., & ALTER, H. J. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-488 · Cited by 328
Self-citationImprovement of PCR amplified DNA sequencing with the aid of detergents
Bachmann, B., Lüke, W., & Hunsmann, G. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.5.1309 · Cited by 282
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children
Lai, M. E., Mazzoleni, A. P., Balestrieri, A., Argiolu, F., De Virgilis, S., Cao, A., Purcell, R. H., & Farci, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91224-6 · Cited by 276
Self-citationNishioka, K., Watanabe, J., Furuta, S., Tanaka, E., Iino, S., Suzuki, H., Tsuji, T., Yano, M., Kuo, G., Choo, Q., et al. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2<429::aid-cncr2820670218>3.0.co;2-# · Cited by 238
Non-A, Non-B Hepatitis in Chimpanzees and Marmosets
Feinstone, S. M., Alter, H. J., Dienes, H. P., Shimizu, Y., Popper, H., Blackmore, D., Sly, D., London, W. T., & Purcell, R. H. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/144.6.588 · Cited by 200
Self-citationKumar, U., Monjardino, J., & Thomas, H. C. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90770-6 · Cited by 143
Scarselli, E., Cerino, A., Esposito, G., Silini, E. M., Mondelli, M. U., & Traboni, C. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4407-4412.1995 · Cited by 81
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 884
Self-citationPathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Metadata
- Authors
- Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J., & Purcell, R. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-12-24
- Volume
- 93
- Issue
- 26
- Pages
- 15394-15399
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1979003966
- Cited by
- 603
- References
- 22
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.